Get the Best Information for Your Region by Switching to the Aeris India Site.

Based on your location, we recommend switching to the Aeris Europe website. There you will find information about Aeris' IoT connectivity services unique to your region.

Get the Best Information for Your Region by Switching to the Aeris Europe Site.

Based on your location, we recommend switching to the Aeris Europe website. There you will find information about Aeris' IoT connectivity services unique to your region.

You can always switch back by using the Switch Regions menu at the top of the website.


The Beginner’s Guide to Understanding M2M Connectivity for Remote Patient Monitoring

iStock_000001925982_MediumToday, healthcare is all about curtailingthe overuse and misuse of healthcare services, which in turn minimizes costs. Remote patient monitoring (RPM) has assisted in making this possible. RPM is a technology used to monitor patients health remotely, when they are not in their physicians immediate care. By passively or actively collecting data from patients wherever they are, providers can realize benefits, from reduced re-admissions to shortened hospital stays to improved clinical outcomes. This helps lower costs and improves chronically ill patients quality of life without the necessity of institutionalization.

As wireless networks and products become an increasingly large part of our everyday lives, cellular machine-to-machine (M2M) technology is replacing public switched telephone network (PSTN) lines as the choice of connecting the remote patient monitoring devices at patient homes.

Berg Insight forecasts that the number of home monitoring systems with integrated communication capabilities will grow at a compound annual growth rate (CAGR) of 26.9 percent between 2011 and 2017 to reach 9.4 million connections worldwide. The number of devices with integrated cellular connectivity increased from 0.73 million in 2011 to about 1.03 million in 2012, and is projected to grow at a CAGR of 46.3 percent to 7.1 million in 2017.

Cellular M2M communications enable the transmission of data from in-home patient devices by monitoring a variety of conditions like diabetes, cardiac arrhythmia, COPD, and Alzheimers. To use cellular M2M technology, the medical monitoring devices either need to have an embedded cellular communication module or be connected to an external cellular modem. This internal module or external modem transmits patient data over a mobile network to the hospital or care provider. While external modems support a plug-n-play model for quick time-to-market solutions, the embedded module will require new development and design of their device.

Customers have a choice in terms of technology when deciding on a M2M solution. They could either use CDMA technology, that is supported by carriers like Verizon Wireless and Sprint or go with GSM technology that is supported by carriers like ATT and T-Mobile.

Depending on the type of application and the amount of data being transmitted from the patient home, customers can choose between 2G, 3G or 4G technologies to support various bandwidth needs.

Lastly, the choice of M2M service provider is a critical decision. While MNOs and MVNOs offer M2M services, Aeris has a very unique value proposition for customers. Aeris is a pioneer and leader in M2M technology, offering connectivity support for a variety of networks, including GSM and CDMA. It owns and operates the only cellular network designed exclusively for machines and has been a leader and pioneer, shaping and driving industry innovation and standards in M2M communications.

With industry-leading machine-to-machine (M2M) cellular communications, Aeris offers the most reliable and flexible CDMA and GSM M2M solutions available today for healthcare providers. As an operator and a technology provider, Aeris can deliver end-to-end M2M solutions for even the most demanding customers. No matter how large or small the deployment, Aeris guarantees the industrys best customer service, highest reliability and lowest total cost of ownership.

Today, M2M communication involves entire networks full of personal and industrial devices talking with each other. The increased development of cellular networks around the world has helped contribute to the industrys growth. The M2M industry is expected to grow from $45 billion in 2013 to reach $200 billion in 2022.

When considering an M2M solution, there are several key factors that you should take into account, including network reliability, redundancy of data centers, cost, support and of course, type of connectivity and technology.

If youre interested in implementing M2M, download our white paper to discover which technologies and connectivity options are right for you. Looking to learn more about how the benefits of M2M and cellular connectivity for your healthcare organization? Explore our resource library.

New Call-to-action